A 55-year-old man with a radiation-induced esophageal stricture experienced an esophagopleural fistula (EPF) as an adverse event of endoscopic balloon dilation therapy. Despite 9 months of covered esophageal stent treatment, the fistula persisted ([Figs. 1](#fig1){ref-type="fig"}A and B). Owing to its recessed position and fibrotic nature, endoclip closure was unlikely to be beneficial ([Fig. 1](#fig1){ref-type="fig"}C). The patient underwent an Eloesser flap thoracostomy, and 2 months later, an atrial septal occluder was deployed ([Fig. 1](#fig1){ref-type="fig"}D; [Video 1](#appsec1){ref-type="sec"}, available online at [www.VideoGIE.org](http://www.VideoGIE.org){#intref0010}). The cavernostomy wound was unpacked. Under endoscopic guidance, an atrial septal occluder device was passed through the fistula and into the esophagus ([Fig. 1](#fig1){ref-type="fig"}E). The proximal end of the occluder was deployed and pulled against the esophageal wall. The distal end was then deployed in a standard fashion ([Fig. 1](#fig1){ref-type="fig"}F). Once the occluder was deployed, the distal end was sutured to the chest wall in 2 locations with 4-0 Polysorb suture (Polysor, Covidien, Medtronic, Minneapolis, Minn), to ensure anchoring and prevent disruption with dressing changes ([Fig. 1](#fig1){ref-type="fig"}G). An initial esophagogram performed 1 week after deployment showed a persistent leak, but time was allowed to achieve tissue ingrowth of the device, and at 4 weeks, closure of the fistula was confirmed ([Figs. 1](#fig1){ref-type="fig"}H and I). An atrial septal occluder device should be considered for persistent EPFs that fail conventional therapy.Figure 1**A**, Abdominal CT scan confirming the persistent esophagopleural fistula *(yellow arrow),* an adequately placed stent *(red arrow),* and a right pleural effusion *(arrowhead).***B**, Esophagram showing contrast medium leaking into the right pleural space *(yellow arrow).***C**, Upper endoscopy revealing a 5-mm fistulous opening in the proximal esophagus *(blue arrow).***D**, Side view of the chest wall demonstrating the thoracostomy window, and the subtle fistulous opening *(yellow arrow).***E**, Scheme of the atrial septal occluder device that was deployed under endoscopic guidance. Copyright 2012 by W.L. Gore & Associates, Inc. Reprinted by permission of W.L. Gore & Associates, Inc. **F**, Endoscopic view of the esophagus, showing the proximal end of the deployed atrial occluder device covering the fistulous opening. **G**, Side view of the chest wall showing the deployed atrial septal occluder covering the fistulous defect. **H**, 4-week follow-up CT scan of the abdomen, showing device and closed defect *(green arrow).***I**, Side view of the chest wall demonstrating the septal occluder covered by fibrous connective tissue *(yellow arrow)*.Figure 1
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Video 1Closure of a persistent esophagopleural fistula with use of an atrial septal occluder device.Video 1Video ScriptVideo Script

Written transcript of the video audio is available online at [www.VideoGIE.org](http://www.VideoGIE.org){#intref0010a}.
